Our Investment Philosophy​

We have a set of guiding principles that inform and shape our investment decisions. While our investment activities are dynamic and evolve over time, our underlying philosophy keeps us focused and provides a unifying theory: 


A company’s pipeline is its lifeblood- we value deep pipelines that provide many opportunities for success

Attractive Price 

For many reasons, company price can differ from company value-we point out companies at good prices relative to their intrinsic value

Cash Position>Burn Rate

Drug development is expensive-we only highlight companies with sufficient cash to reach their next major milestone


Variant Perspectives

The mainstream view can often be incorrect - We look for opportunities where our understanding of technologies, disorders, patients, and data indicates the mainstream investors are under-pricing a stock


Having a competitive edge is paramount - we gravitate toward biopharma companies whose drugs have an advantage over the current standard of care; sometimes this is based on revolutionary new science, but often it's for practical reasons like as ease of administration/compliance


Drug development takes strong management communication, oversight and systems - We prefer management teams with proven track records who keep investors updated regularly


Understanding the market potential for a new drug is important; we look for companies developing drugs in large market segments that often exceed $1 billion

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon